Intralesional nivolumab appeared effective for treating precancerous oral lesions in a phase 1, open-label, dose-escalation trial.

Injecting nivolumab (Opdivo) directly into precancerous oral lesions led to reduction in lesion size and allowed some ...

The injection of immunotherapy directly into precancerous oral lesions may reduce risk for progression to cancer and help ...

Benign oral HPV lesions are mostly asymptomatic and may persist or relapse spontaneously. The first part of this exercise will explain how to diagnose and treat some of the most common HPV-associated ...

Direct injection of a low dose of the immune checkpoint inhibitor nivolumab into precancerous oral lesions significantly reduced lesion size and risk of cancer progression, sparing most patients from ...

Oral lesions can range from harmless irritations to early signs of cancer, making timely detection critical. Dentists play a ...

SAN FRANCISCO - While commercially available optical tools can help clinicians identify premalignant lesions in the oral cavity, the prevalence of confounding lesions increases the rate of false ...

Detection, evaluation, and management of oral lesions are critical responsibilities for oral healthcare providers. Although most oral lesions are benign, they can represent chronic mucosal disorders ...

Intralesional nivolumab seems effective for reducing the size of precancerous oral lesions, according to a study presented at the annual meeting of the American Association for Cancer Research, held ...

Several case histories have been reported in the literature, with the prevalence of HPV DNA detection in cancers ranging from 0% to 100%, depending on the population, combination of topographies, type ...